Matches in Wikidata for { <http://www.wikidata.org/entity/Q94141733> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q94141733 description "article scientifique publié en 2019" @default.
- Q94141733 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94141733 description "wetenschappelijk artikel" @default.
- Q94141733 description "наукова стаття, опублікована в жовтні 2019" @default.
- Q94141733 name "2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species" @default.
- Q94141733 name "2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species" @default.
- Q94141733 type Item @default.
- Q94141733 label "2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species" @default.
- Q94141733 label "2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species" @default.
- Q94141733 prefLabel "2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species" @default.
- Q94141733 prefLabel "2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species" @default.
- Q94141733 P1433 Q94141733-5CB23F98-76AB-49F3-835E-9DDD48DCD558 @default.
- Q94141733 P1476 Q94141733-54374CA1-C34C-4D94-98B3-EBEC67F8D59E @default.
- Q94141733 P2093 Q94141733-29ADA5FC-D991-4774-9328-32AEC05519DA @default.
- Q94141733 P2093 Q94141733-6DF136EE-6A8A-44A3-9C77-8C41EC1DB52C @default.
- Q94141733 P2093 Q94141733-83C45DC6-529A-4537-BFCE-6E7858AEF7FD @default.
- Q94141733 P2093 Q94141733-95005E68-DE42-49E5-9A66-DC5DB257DDAA @default.
- Q94141733 P2093 Q94141733-A9C1CD4B-994E-489C-B552-864F645928FE @default.
- Q94141733 P275 Q94141733-1757da4d-659c-4e7d-8308-38d3f4942684 @default.
- Q94141733 P304 Q94141733-96BA0861-CF1C-4EB6-953B-73D263AD8120 @default.
- Q94141733 P31 Q94141733-0C66630A-E1D6-4914-B7F1-067484AC5C4F @default.
- Q94141733 P356 Q94141733-E4DE85A7-0980-45B1-A59F-EB8C6F331FB0 @default.
- Q94141733 P433 Q94141733-9BD503AA-0E67-4300-A217-CDD60491374B @default.
- Q94141733 P478 Q94141733-4A56A000-BFB4-4C24-8F8C-C973142B775C @default.
- Q94141733 P577 Q94141733-43DE94E8-3FF6-4A16-A1A9-FCD4A2CB5B78 @default.
- Q94141733 P6216 Q94141733-a319bcf8-4af3-40a8-aef5-abb66f388a4d @default.
- Q94141733 P921 Q94141733-2457F6E5-41A4-41DE-B65C-6A82250F4E4F @default.
- Q94141733 P921 Q94141733-4613284D-0558-45C4-B8F9-6BF0280F8F4E @default.
- Q94141733 P932 Q94141733-05693D78-5632-48F6-99CE-7374C0222BF7 @default.
- Q94141733 P356 OFZ360.1968 @default.
- Q94141733 P1433 Q27725953 @default.
- Q94141733 P1476 "2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species" @default.
- Q94141733 P2093 "Amira A Bhalodi" @default.
- Q94141733 P2093 "Kyle Spafford" @default.
- Q94141733 P2093 "Niels Oppermann" @default.
- Q94141733 P2093 "Romney Humphries" @default.
- Q94141733 P2093 "Shawn H MacVane" @default.
- Q94141733 P275 Q24082749 @default.
- Q94141733 P304 "S785-S785" @default.
- Q94141733 P31 Q13442814 @default.
- Q94141733 P356 "10.1093/OFID/OFZ360.1968" @default.
- Q94141733 P433 "Suppl 2" @default.
- Q94141733 P478 "6" @default.
- Q94141733 P577 "2019-10-23T00:00:00Z" @default.
- Q94141733 P6216 Q50423863 @default.
- Q94141733 P921 Q25419 @default.
- Q94141733 P921 Q421713 @default.
- Q94141733 P932 "6810734" @default.